메뉴 건너뛰기
Neurology
Volumn 77, Issue 15, 2011, Pages 1416-1417
Levodopa toxicity and parkinson disease : Still a need for equipoise
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;
EID: 82955235717     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318232ac0a     Document Type: Editorial
Times cited : (20)
References (10)
  • 2
    • 0035834360 scopus 로고    scopus 로고
    • Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
    • DOI 10.1126/science.1063522
    • Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 2001;294: 1346-1349. (Pubitemid 33063102)
    • (2001) Science , vol.294 , Issue.5545 , pp. 1346-1349
    • Conway, K.A.1    Rochet, J.-C.2    Bieganski, R.M.3    Lansbury Jr., P.T.4
  • 3
    • 38849174979 scopus 로고    scopus 로고
    • Dopamine-modified alpha synuclein blocks chaperonemediated autophagy
    • Martinez-Vicente M, Tallozy Z, Kaushik S, et al. Dopamine-modified alpha synuclein blocks chaperonemediated autophagy. J Clin Invest 2008;118:777-788.
    • (2008) J Clin Invest , vol.118 , pp. 777-788
    • Martinez-Vicente, M.1    Tallozy, Z.2    Kaushik, S.3
  • 5
    • 0037012478 scopus 로고    scopus 로고
    • Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression
    • Parkinson Study Group
    • Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 2002;287:1653-1661.
    • (2002) JAMA , vol.287 , pp. 1653-1661
  • 6
    • 19744378296 scopus 로고    scopus 로고
    • Levodopa and the progression of parkinson disease
    • Parkinson Study Group
    • Fahn S, Oakes D, Shoulson I, et al, Parkinson Study Group. Levodopa and the progression of Parkinson disease. N Engl J Med 2004;351:2498-2508.
    • (2004) N Engl J Med , vol.351 , pp. 2498-2508
    • Fahn, S.1    Oakes, D.2    Shoulson, I.3
  • 7
    • 82955167998 scopus 로고    scopus 로고
    • Does levodopa accelerate the pathologic process in Parkinson disease brain?
    • Parkkinen L, O'Sullivan SS, Kuoppamäki M, et al. Does levodopa accelerate the pathologic process in Parkinson disease brain? Neurology 2011;77:1420-1426.
    • (2011) Neurology , vol.77 , pp. 1420-1426
    • Parkkinen, L.1    O'Sullivan, S.S.2    Kuoppamäki, M.3
  • 8
    • 3142540683 scopus 로고    scopus 로고
    • Lewy-body formation is an aggresome-related process: A hypothesis
    • DOI 10.1016/S1474-4422(04)00827-0, PII S1474442204008270
    • Olanow CW, Perl DP, DeMartino GN, McNaught KS. Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 2004;3:496-503. (Pubitemid 38903101)
    • (2004) Lancet Neurology , vol.3 , Issue.8 , pp. 496-503
    • Olanow, C.W.1    Perl, D.P.2    DeMartino, G.N.3    McNaught, K.St.P.4
  • 9
    • 0026517873 scopus 로고
    • A review of recent advances in stereology for quantifying neural structure
    • Mayhew TM. A review of recent advances in stereology for quantifying neural structure. J Neurocytol 1992;21:313-328.
    • (1992) J Neurocytol , vol.21 , pp. 313-328
    • Mayhew, T.M.1
  • 10
    • 0036457026 scopus 로고    scopus 로고
    • Design-based stereological methods for counting neurons
    • DOI 10.1016/S0079-6123(02)35006-4
    • West MJ. Design-based stereological methods for counting neurons. Prog Brain Res 2002;135:43-51. (Pubitemid 35461005)
    • (2002) Progress in Brain Research , vol.135 , pp. 43-51
    • West, M.J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.